Together, results from both pharmacological inhibition and genetic depletion studies converge to support the conclusion that co-inhibition of BET and CDK7 imposes synergistic lethality against both human and rodent BETi-resistant leukemia cells in vitro. Here, DNER is linked to leukemia.